Bumetanide for autism spectrum disorder: Current evidence (eng)
-No abstract is available since it is structured as a "Letter to the Editor".
Main Authors: | Mazlum Çöpür, Sidar Copur |
---|---|
Format: | Article |
Language: | English |
Published: |
ANP Publishing
2020-11-01
|
Series: | Klinik Psikiyatri Dergisi |
Subjects: | |
Online Access: | https://www.journalagent.com/z4/download_fulltext.asp?pdir=kpd&un=KPD-47123 |
Similar Items
-
Bumetanide Therapeutic Effect in Children and Adolescents With Autism Spectrum Disorder: A Review Study
by: Raheleh Mollajani, et al.
Published: (2019-09-01) -
Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol
by: Bruining, H., et al.
Published: (2022) -
GABAergic signaling as therapeutic target for Autism Spectrum Disorders
by: Giada eCellot, et al.
Published: (2014-07-01) -
Failure of the Nemo trial: bumetanide is a promising agent to treat many brain disorders but not newborn seizures
by: Yehezkel eBen-Ari, et al.
Published: (2016-04-01) -
A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
by: Nappi JM
Published: (2013-03-01)